Eton Pharmaceuticals, Inc. ( ETON) - Key Metrics
ETON Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $1.36 | $0.42 | $0.26 | $0.26 |
| 2026Q1 | $0.89 | $0.06 | $0.27 | $0.27 |
| 2025Q4 | $0.79 | $0.06 | -$0.43 | -$0.43 |
| 2025Q3 | $0.84 | -$0.07 | $0.45 | $0.44 |
| 2025Q2 | $0.70 | -$0.10 | $0.30 | $0.30 |
ETON Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 21.55 |
| 2026Q1 | 0% | 102.83 |
| 2025Q4 | 0% | 76.86 |
| 2025Q3 | 0% | -77.61 |
| 2025Q2 | 0% | -37.07 |
ETON Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 0.73% | 0% |
| 2026Q1 | 1.09% | 0% |
| 2025Q4 | -2.55% | 0% |
| 2025Q3 | 2.01% | 0% |
| 2025Q2 | 2.08% | 0% |
ETON
Price: $51.70
52 week price:
Payout Ratio Range:
Earnings Per Share: 0.39 USD
P/E Ratio: 157.64
Exchange: NGM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 36257
Market Capitalization: 1.5 billion